Line 332: |
Line 332: |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Precursor Lymphoid Neoplasms ||'''''Overview'''''|| ||Yassmine Akkari (YA) |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities||'''''Overview'''''|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |T-Lymphoblastic Leukemia/Lymphoma||'''''Overview'''''|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | || || || |
| | | | | |
| | | | | |